BioCryst Pharmaceuticals Stock Is Tumbling: What’s Going On? – BioCryst Pharmaceuticals (NASDAQ:BCRX)
[ad_1] BioCryst Pharmaceuticals Inc BCRX shares are trading lower Monday after the company announced preliminary fourth-quarter and full-year results for Orladeyo. What Happened: BioCryst expects fourth-quarter Orladeyo net revenue of $70.7 million, representing…